14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CASBF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

CASBF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 13, 2022 Jul 13, 2022 Jul 13, 2022 $0.119 1.26%

FAQ

What is the symbol for CanSino Biologics Inc. Stock and on which exchange is it traded?
The symbol for CanSino Biologics Inc. is CASBF and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell CanSino Biologics Inc. Stock?
CanSino Biologics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy CanSino Biologics Inc. Stock?
CanSino Biologics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CanSino Biologics Inc. Stock.

What's the current price of CanSino Biologics Inc. Stock?
As of the end of day on the May 20, 2024, the price of an CanSino Biologics Inc. (CASBF) share was $2.10.

What is the 52-week high and low for CanSino Biologics Inc. Stock?
The 52-week high for CanSino Biologics Inc. Stock is $4.50 and the 52-week low is $1.86.

What is the market capitalization of CanSino Biologics Inc. Stock?
As of the May 20, 2024, the market capitalization of CanSino Biologics Inc. is 747.731M.

When is the next earnings date for CanSino Biologics Inc.?
The upcoming earnings date for CanSino Biologics Inc. is Jun 28, 2024.
Click to get the best stock tips daily for free!

About CanSino Biologics Inc.

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the we... CASBF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT